Lauren Mateja, Managing Editor

Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.

Atopic dermatitis is a chronic disease requiring long-term monitoring of symptoms and triggers. Patients can proactively monitor their eczema with a new, easy-to-use mobile app.

While a number of new therapeutic agents have been approved to treat the signs of rosacea, much needed research is underway to better understand its pathogenesis.

As a largely misunderstood and misdiagnosed disease, hidradenitis suppurativa is beginning to come to the forefront of dermatologic research.

The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know what to look for?

A recent survey by the National Rosacea Society revealed that while patients were satisfied with their current therapies, older patients were more likely to use older treatments, signaling a need to revisit management plans.

As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.

Continuing education is critical to improving your practice and, ultimately, patient care. Preview the latest offerings in continuing medical education, from virtual meetings to currently scheduled live conferences.

Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.

Treating psoriasis in our pediatric patients is generally similar to treating psoriasis in adults, but the psychosocial burden on the patient and their caregivers should be a point of emphasis in the visits and approach to management.